Related Experiment Videos
[Acute coronary syndrome--better risk stratification by determination of inflammatory parameters?]
Andreas Link1, Michael Böhm, Georg Nickenig
1Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, Homburg/Saar. andreas.link@telemed.de
Insights
Inflammation plays a key role in coronary atherosclerosis and plaque rupture. Biomarkers like C-reactive protein help stratify risk for cardiovascular complications, guiding treatment strategies.
Area of Science:
- Cardiovascular medicine
- Immunology
- Pathophysiology
Context:
- Coronary atherosclerosis and plaque rupture involve smooth vascular cell growth, platelet activation, coagulation, and inflammation.
- Inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and adhesion molecules are crucial in cardiovascular disease prognosis.
- Acute coronary syndromes (ACS) are significantly influenced by these inflammatory processes.
Purpose:
- To highlight the role of inflammation in coronary atherosclerosis and plaque rupture.
- To discuss the prognostic value of inflammatory markers in cardiovascular complications.
- To outline risk stratification and therapeutic strategies based on inflammatory markers and early complication indicators.
Summary:
- Positive troponin T tests indicate early complications, benefiting from aggressive therapy with GP IIb/IIIa receptor antagonists and acute coronary intervention.
- C-reactive protein (CRP) predicts late complications like restenosis, reinfarction, and cardiac death, warranting close monitoring and anti-inflammatory therapy with aspirin and statins.
- Inflammatory markers are key predictors of both early and late cardiovascular events, guiding tailored treatment approaches.
Impact:
- Provides a framework for understanding the multifactorial nature of coronary atherosclerosis, incorporating inflammation.
- Emphasizes the clinical utility of inflammatory biomarkers for risk stratification in acute coronary syndromes.
- Informs therapeutic decisions, advocating for targeted anti-inflammatory strategies and interventions based on specific risk profiles.
Background:
In the past years coronary atherosclerosis and plaque rupture have been characterized not only as a problem of growth of smooth vascular cells, of activated thrombocytes and coagulation but also of inflammation.
Parameters Of Inflammation:
Several studies have demonstrated the importance of C-reactive protein as a marker for cardiovascular complications. Also interleukin-6, tumor necrosis factor-alpha and adhesion molecules are discussed as predictors of a poor prognosis in patients with acute coronary syndromes.
Risk Stratification:
A positive troponin T test is correlated with an increased rate of early complications; thus, these patients benefit from an aggressive therapy with GP IIb/IIIa receptor antagonists and acute coronary intervention. The C-reactive protein is predictive for late complications such as restenosis, reinfarction and death due to cardiac events; these patients benefit from close controls and from an anti-inflammatory therapy with acetylsalicyclic acid and statins.